$CME

CME Posts Record Q3 Revenue Despite Lower Daily Trading Volume

CME Group reported record Q3 revenue of $1.737bn, up 1.8% from Q2, despite a 1.3% drop in average daily volume. The increase was driven by two extra trading days and higher data service revenue. Clearing fees rose 1.9% to $1.378bn. CME launched new contracts but their impact on revenue is unclear. Fee changes in October could add 0.5%–1% to annual revenue.

Original reporting
Published Oct 21, 2026, 9:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 10:53 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CME Posts Record Q3 Revenue Despite Lower Daily Trading Volume — source image
Decision brief

The 30-second read

$CMENeutralMed
01

Why it matters

The Q3 earnings beat highlights resilience in fee revenue despite lower daily volumes, signaling potential stability for traders relying on CME infrastructure.

02

Market read

CME's earnings set expectations for future fee growth and may affect pricing of CME‑linked ETFs and futures contracts.

03

What to watch

Pending fee changes effective Oct 1 could boost Q4 results, and new contract launches may add incremental revenue not yet reflected.

Relevance 7/10Novelty 8/10Timing: released with the Q3 earnings on the same day

Background

CME Group is the world’s largest derivatives exchange, providing clearing and data services across multiple asset classes.

Company-level read

Ticker impact

$CMENeutralHigh confidence
Context

CME Group reported record Q3 revenue of $1.737 bn, a 1.8% increase despite lower daily ADV, marking its first earnings disclosure for the quarter.

Expected impact

likely slight upward pressure as investors price in revenue growth and fee increase, tempered by lower daily trading activity

Evidence & confidence

The earnings numbers are fresh and better than prior quarter, while fee changes are pending, creating a balanced outlook.

Market effects

Futures and options market may see modest demand for CME's data services and fee-driven revenue, but overall trading volume remains flat.

U.S. market participants may adjust exposure to CME-related ETFs and derivatives.

CME's global clearing role means the earnings could influence sentiment across major futures exchanges worldwide.

Counterpoint

The revenue increase is driven mainly by extra trading days; without the calendar effect, growth may stall, suggesting caution.

Key entities

  • CME Group

    Global derivatives exchange operator.

Related articles

$CMEMed

CME Maintained by Barclays -- Price Target Raised to $321

Barclays maintained an Equal-Weight rating on CME Group (CME) but raised its price target to $321 from $281. CME's stock is currently priced at $305.65, which is 10.8% overvalued according to its GF Value™ of $275.98. The company has a GF Score™ of 88/100, indicating strong performance in profitability and growth. 19 gurus hold CME, with 12 adding to their positions recently.

$CMEMed

CME Maintained by Wells Fargo -- Price Target Raised to $333

Wells Fargo maintained an Overweight rating for CME Group and raised its price target to $333 from $315. CME operates the world's largest derivatives marketplace. GuruFocus values CME at $275.98, indicating a 10.9% overvaluation at its current price of $306.07. The company has a GF Score of 88, with strong growth and profitability metrics.

$CMEHigh

JPMorgan upgrades CME Group stock rating on rates outlook

JPMorgan upgraded CME Group (CME) from Underweight to Overweight, raising its price target to $367. The firm cited a supportive interest rate environment, higher trading velocity, and market uncertainty as favorable for CME. The stock currently trades at $295.79. CME reported stronger-than-expected Q3 2026 results, with adjusted EPS of $3.02 and revenue of $1.74 billion, up 13% YoY.

$CMEMed

CME Group Inc (CME) (Q3 2026) Earnings Call Highlights: Record Volumes and Revenue

CME Group reported record Q3 2026 results, with $100 billion in daily margin savings driven by increased activity across asset classes. Market data business grew 20%, with diverse demand sources. CEO Terry Duffy discussed legal and strategic updates, including the CFTC perpetuals lawsuit and 24/7 trading plans. New products like single stock futures and TreasuryLink saw strong adoption. CME emphasized disciplined capital allocation and pricing adjustments.